PBA-HA is a dual-functional HA derivative combining methacrylate groups (photocrosslinkable) with phenylboronic acid groups (glucose-sensitive). PBA groups (pKa ~8.8 free; lowered to ~7.4 in hydrogel) form reversible cyclic boronic ester bonds with molecules containing vicinal diol (1,2-diol or 1,3-diol) groups — catechins (EGCG), catechol-containing antioxidants (gallic acid, dopamine), flavonoids, and polyphenols. In hyperglycemic environments (>10 mM glucose) — typical of diabetic wound exudate where interstitial glucose is 2-4× blood levels — glucose molecules competitively bind to PBA groups, displacing the therapeutic diol bonds and triggering on-demand drug release. This creates a closed-loop smart hydrogel: the higher the local glucose concentration, the faster the therapeutic release — delivering treatment automatically in response to the wound’s own hyperglycemic condition without external pumps, sensors, or intervention.

Standard MA-HA provides photocrosslinking only — a passive hydrogel scaffold with no environmental responsiveness. PBA-HA adds a second, orthogonal chemical functionality: glucose-responsive dynamic covalent crosslinks via PBA groups (15-30%). The two functionalization parameters — degree of methacrylation (40-60%) and degree of PBA functionalization (15-30%) — are independently tunable, allowing researchers to separately program the hydrogel’s structural integrity (via MA crosslink density → stiffness, swelling, degradation rate) and its responsive release profile (via PBA content → glucose affinity, release kinetics, dynamic bond density). This transforms the hydrogel from passive structural support into an active, environment-sensing biomaterial. For diabetic wound healing applications, this glucose-responsiveness is the critical differentiator — enabling automatic therapeutic release triggered by the wound’s endogenous hyperglycemic condition, creating a self-regulating delivery system.

Any molecule containing vicinal diol (1,2-diol or 1,3-diol) groups can form reversible boronic ester bonds with PBA. Common compatible therapeutics include: Catechins — EGCG (epigallocatechin gallate from green tea, potent antioxidant with demonstrated diabetic wound healing efficacy via Nrf2/HO-1 pathway activation), ECG, EGC; Catechol-containing antioxidants — gallic acid, dopamine, norepinephrine, L-DOPA; Flavonoids — quercetin, myricetin, luteolin, fisetin, kaempferol; Polyphenols — tannic acid, proanthocyanidins, resveratrol. Therapeutic release is triggered when glucose competitively displaces the drug-diol bond at concentrations >10 mM (glucose-boronate Kf ~10-100 M⁻¹ with mM concentration advantage over μM-nM drug levels). For molecules without natural diol groups, chemical derivatization strategies (e.g., conjugating a glycerol, catechol, or sugar linker) can expand the range of compatible payloads.

Yes. PBA-HA retains full photocrosslinking capability via its methacrylate groups (40-60% DoM). Compatible photoinitiators: LAP (lithium phenyl-2,4,6-trimethylbenzoylphosphinate, 405 nm visible light, 0.05-0.5% w/v — recommended for cell-containing applications due to low cytotoxicity and compatibility with standard bioprinter LED sources), Irgacure 2959 (2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone, 365 nm UV, 0.05-0.5% w/v — for acellular scaffolds), and Ruthenium/SPS (Ru(II)bpy₃²⁺/S₂O₈²⁻, visible 400-450 nm, 1/10 mM — highest cytocompatibility, slower gelation). The photocrosslinking forms the primary hydrogel network providing structural integrity and shape fidelity; the PBA-diol bonds provide the secondary, glucose-responsive dynamic network enabling stimuli-responsive behavior. Both mechanisms operate orthogonally — light initiates methacrylate polymerization to set the hydrogel, while glucose concentration modulates boronic ester bond stability to control drug release — enabling independent optimization of mechanical and responsive properties.

Every shipment includes: COA (¹H-NMR spectrum confirming both MA functionalization — vinyl protons δ 5.6/6.0 ppm, methyl δ 1.8 ppm — and PBA functionalization — aromatic protons δ 7.2-7.8 ppm, integration ratio vs HA N-acetyl methyl δ 2.0 ppm; degree of methacrylation 40-60%; PBA functionalization 15-30%; endotoxin ≤100 EU/g LAL; sterility USP <71>; parent HA MW by GPC-MALLS; solubility verification; heavy metals; microbial panel USP <61>/<62>; residual PBA precursor — not detected by ¹H-NMR), MSDS, ¹H-NMR Spectral Report (full peak assignments and integration for MA and PBA degree of substitution calculation — signed and dated), Stability Data (MA and PBA functionalization re-verified at 0/3/6 months by ¹H-NMR), and Complete Lot Traceability. ISO 9001:2015 and c-GMP (ICH Q7) manufacturing ensures batch-to-batch consistency in both methacrylation and PBA functionalization degrees. All products labeled Research Use Only (RUO). Free sample available for qualified researchers.